ACTINIUM PHARMACEUTICALS, INC. Operating Loss Carryforwards
ACTINIUM PHARMACEUTICALS, INC. (ATNM) had Operating Loss Carryforwards of $104.80 million as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Income Taxes
us-gaap:OperatingLossCarryforwards · last filed 2026-03-30
- 2025-12-31: Operating Loss Carryforwards $104.80M.
- 2024-12-31: Operating Loss Carryforwards $104.80M.
- 2023-12-31: Operating Loss Carryforwards $104.80M.
- 2015-12-31: Operating Loss Carryforwards $85.00M.
| Period end | Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $104.80M 10-K · filed 2026-03-30 |
| 2024-12-31 | $104.80M 10-K · filed 2025-03-31 |
| 2023-12-31 | $104.80M 10-K · filed 2024-03-29 |
| 2015-12-31 | $85.00M 10-K · filed 2016-03-11 |
| 2014-12-31 | $67.00M 10-K · filed 2015-03-16 |
| 2013-12-31 | $52.60M 10-K · filed 2014-02-28 |
| 2012-12-31 | $43.00M 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |